 is
reasonable to scan at 1 year and annually thereafter until
disease seems to be stable, deÔ¨Åned as no restenosis is
observed in two consecutive annual scans. Annual
follow-up also allows careful reassessment of risk factors
and medical treatment optimization. More frequent
follow-up can be considered for higher risk groups.
Summary and recommendations.
1. After CEA or CAS, we recommend surveillance with
duplex
ultrasound
examination
at
baseline
